Zoetis Inc. $ZTS Shares Sold by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 2.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 221,041 shares of the company’s stock after selling 5,400 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund owned 0.05% of Zoetis worth $32,343,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Halbert Hargrove Global Advisors LLC boosted its holdings in shares of Zoetis by 496.6% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after acquiring an additional 144 shares during the last quarter. Financial Consulate Inc. purchased a new position in shares of Zoetis during the third quarter worth $39,000. SJS Investment Consulting Inc. lifted its position in Zoetis by 1,606.3% during the third quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock valued at $40,000 after purchasing an additional 257 shares during the period. TruNorth Capital Management LLC purchased a new stake in Zoetis in the third quarter valued at $42,000. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new stake in Zoetis in the third quarter valued at $46,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ZTS. BTIG Research reiterated a “buy” rating and set a $160.00 price objective on shares of Zoetis in a research note on Thursday, February 26th. Piper Sandler restated a “neutral” rating and issued a $135.00 target price (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Barclays began coverage on Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. William Blair reissued an “outperform” rating on shares of Zoetis in a report on Monday, March 2nd. Finally, Morgan Stanley set a $160.00 price objective on Zoetis in a research report on Thursday, December 18th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Zoetis presently has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Trading Down 0.6%

ZTS stock opened at $121.54 on Friday. The company’s 50-day simple moving average is $126.06 and its 200-day simple moving average is $133.05. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $177.00. The firm has a market cap of $51.31 billion, a P/E ratio of 20.19, a PEG ratio of 1.85 and a beta of 0.95.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be given a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. Zoetis’s payout ratio is 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.